focus -WSS

focus

author：leisure time 2025-09-28 01:38:15 - browse：9967

empty test tubes in the hand. -- first opinion coverage from STAT — Adobe

The Food and Drug Administration on Friday announced its intention to start regulating tests developed in laboratories — closing the “Theranos loophole” that has allowed inaccurate tests to slip through the cracks.

Lawmakers came close last year to passing a bill that would have given the FDA this authority, but it was ultimately rejected by Republicans who sympathized with the labs in academic medical centers and hospitals that opposed the provision. FDA Commissioner Robert Califf said at the time that if the bill failed, the agency would take matters into its own hands.

The proposed rule fulfills that promise, adding lab diagnostics to the list of devices that fall under FDA enforcement — a move that patient groups and non-lab test makers support, and that laboratories are likely to dispute. When the FDA started regulating medical devices in 1976, lab-developed tests were simple and offered mostly to local patient populations. The agency generally allowed labs to use these tests without submitting proof of their efficacy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： A pediatrician calls for Congress to pass the child tax credit deal

WSS

Listen: Racing for gene therapy & a pioneering approval

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Eye stem cell transplant could help restore vision in injured people

The inclusion problem at the heart of rehabilitation research

Flu vaccine reformulation won't be easy, manufacturers warn

Pumping milk in bathrooms at health conferences is common

knowledge

focus

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare bonuses could stop drug shortages under Senate plan

Duchenne breakthrough therapy leaves behind pioneering families

Microsoft launches AI tool for clinical documentation through Epic

Wildfire smoke exposes gaps in outdoor worker protections

ActiGraph execs on goal of drug approvals with digital endpoints

Supreme Court strikes down use of affirmative action

Liz Cheney makes 1st public comment since Trump's election interference indictments

Hepatitis C has a cure — but many Americans still lack access to it

Trump's false claims about Georgia's 2020 election long debunked

knowledge

CVS is on a mission to consolidate health care. Will it work?

The inclusion problem at the heart of rehabilitation research

Patient advocates sound warning on FDA proposal on salt intake

Mass General, Mayo Clinic look to monetize custom

High breast density mammograms need follow

Microsoft launches AI tool for clinical documentation through Epic

focus

hotspot

leisure time

entertainment